Abstract
Immune hemolytic anemia and reactivated tuberculosis developed in a patient treated with α-interferon for Kaposi's sarcoma and splenic non-Hodgkin's lymphoma. The hemolytic process stopped on cessation of interferon and initiation of corticosteroid therapy, and the Coomb's test became negative. The possibility of reactivation of tuberculosis by interferon is discussed.
Original language | English |
---|---|
Pages (from-to) | 445-448+503 |
Journal | Harefuah |
Volume | 127 |
Issue number | 11 |
State | Published - 1 Jan 1994 |
ASJC Scopus subject areas
- General Medicine